Our genes are like instruction manuals for life, and the way those instructions are edited can shape how cells behave. One of the ways cells fine-tune gene activity is through alternative splicing, a process that creates different versions of RNA messages from the same gene. When splicing goes awry, it can contribute to diseases such as cancer. Traditional bulk RNA sequencing has helped scientists understand splicing on average across many cells, but it misses the rich diversity among individual cells, and it often can’t read full-length RNA molecules needed to see the whole story.

To overcome these challenges, researchers at James Cook University and other institutions have been exploring how single-cell long-read sequencing, sometimes called SCLR-seq, can offer a clearer and more detailed view of RNA messages inside individual cells by capturing their full length. Big advances in sequencing technology now allow scientists to join the power of long-read RNA sequencing, which can read entire RNA molecules, with the precision of single-cell resolution, which distinguishes one cell from another.

Short-read single-cell RNA sequencing is widely used because it can profile thousands of cells at once, but it sequences short fragments of RNA. These short snippets make it hard to reconstruct the full sequence of RNA isoforms, the various forms made when different exons are included or skipped. Long-read RNA sequencing, in contrast, can follow entire RNA molecules from start to finish allowing researchers to identify novel splice variants, measure how often particular splicing events occur, and even detect fusion transcripts, which are sometimes associated with cancer and other diseases.

By bringing long reads to the single-cell level, SCLR-seq gives researchers the best of both worlds, combining the ability to see how each cell differs with the detailed view of full-length RNA. This combined approach helps uncover how alternative splicing varies from cell to cell, and how those patterns may be linked to disease processes or responses to treatment. It also drives development of specialized bioinformatics tools and analysis strategies to handle the unique challenges of this data.

As sequencing technologies and computational methods continue to improve, single-cell long-read approaches will likely become an even more powerful tool for understanding complex biological systems at an unprecedented level of detail. Scientists hope that deeper insight into isoform regulation and splicing diversity will eventually lead to new ways to diagnose and treat human diseases.